1. Home
  2. ABVX vs ATGL Comparison

ABVX vs ATGL Comparison

Compare ABVX & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • ATGL
  • Stock Information
  • Founded
  • ABVX 2013
  • ATGL 2017
  • Country
  • ABVX France
  • ATGL Hong Kong
  • Employees
  • ABVX N/A
  • ATGL N/A
  • Industry
  • ABVX
  • ATGL
  • Sector
  • ABVX
  • ATGL
  • Exchange
  • ABVX Nasdaq
  • ATGL Nasdaq
  • Market Cap
  • ABVX 451.5M
  • ATGL 409.9M
  • IPO Year
  • ABVX N/A
  • ATGL 2023
  • Fundamental
  • Price
  • ABVX $6.71
  • ATGL $24.30
  • Analyst Decision
  • ABVX Strong Buy
  • ATGL
  • Analyst Count
  • ABVX 5
  • ATGL 0
  • Target Price
  • ABVX $33.80
  • ATGL N/A
  • AVG Volume (30 Days)
  • ABVX 96.0K
  • ATGL 8.0K
  • Earning Date
  • ABVX 03-24-2025
  • ATGL 12-31-2024
  • Dividend Yield
  • ABVX N/A
  • ATGL N/A
  • EPS Growth
  • ABVX N/A
  • ATGL N/A
  • EPS
  • ABVX N/A
  • ATGL N/A
  • Revenue
  • ABVX $11,172,999.00
  • ATGL $1,590,148.00
  • Revenue This Year
  • ABVX $284.20
  • ATGL N/A
  • Revenue Next Year
  • ABVX N/A
  • ATGL N/A
  • P/E Ratio
  • ABVX N/A
  • ATGL N/A
  • Revenue Growth
  • ABVX 135.94
  • ATGL 42.17
  • 52 Week Low
  • ABVX $4.77
  • ATGL $1.15
  • 52 Week High
  • ABVX $14.75
  • ATGL $57.32
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 50.68
  • ATGL 40.74
  • Support Level
  • ABVX $6.54
  • ATGL $25.57
  • Resistance Level
  • ABVX $7.83
  • ATGL $26.63
  • Average True Range (ATR)
  • ABVX 0.54
  • ATGL 1.24
  • MACD
  • ABVX -0.00
  • ATGL -0.31
  • Stochastic Oscillator
  • ABVX 30.00
  • ATGL 9.21

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

Share on Social Networks: